These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 6782529)
1. Protecting the unborn: Dow's experience. Rao KS; Schwetz BA Occup Health Saf; 1981 Mar; 50(3):53-6, 58-61. PubMed ID: 6782529 [No Abstract] [Full Text] [Related]
2. Drugs and pregnancy. Scott A J Ir Med Assoc; 1974 Mar; 67(5):123-6. PubMed ID: 4815646 [No Abstract] [Full Text] [Related]
3. Dow's approach to toxicity and exposure guideline development in industrial hygiene. Socha GE J Occup Med; 1975 Apr; 17(4):251-3. PubMed ID: 1127476 [No Abstract] [Full Text] [Related]
4. Improper interpretation of data concerning teratogenicity: a case report. Staples RE Prog Clin Biol Res; 1985; 163C():161-3. PubMed ID: 3921981 [No Abstract] [Full Text] [Related]
5. [Principles and concepts of teratogenesis. I. The teratogenic injury (author's transl)]. Rooze M Rev Med Brux; 1980 Oct; 1(8):523-33. PubMed ID: 6781025 [No Abstract] [Full Text] [Related]
6. NTP-CERHR Expert Panel report on the reproductive and developmental toxicity of ethylene glycol. Center for the Evaluation of Risks to Human Reproduction Reprod Toxicol; 2004 Jun; 18(4):457-532. PubMed ID: 15135850 [No Abstract] [Full Text] [Related]
7. [Evaluation of occupational teratogenic hazards based on data from the Hungarian Case-Control Surveillance System for Congenital Anomalies]. Király J; Czeizel E Orv Hetil; 1986 Aug; 127(31):1871-6. PubMed ID: 3737192 [No Abstract] [Full Text] [Related]
9. [Prevention of foetal risks]. Grangé G Rev Prat; 2007 Jun; 57(11):1255-60. PubMed ID: 17691272 [No Abstract] [Full Text] [Related]
10. FDA problems with medications in the marketplace: IV. Drugs and the unborn. Archambault GF Hosp Formul; 1977 Jan; 12(1):56. PubMed ID: 10236016 [No Abstract] [Full Text] [Related]
11. [Suspected connection between exposure to hexachlorophene and birth of malformed infants]. Halling H Lakartidningen; 1977 Feb; 74(7):542-6. PubMed ID: 839891 [No Abstract] [Full Text] [Related]
12. [Occupational exposure of women to inorganic lead (author's transl)]. Cavalleri A; Candura F Med Lav; 1979; 70(5):341-4. PubMed ID: 554911 [No Abstract] [Full Text] [Related]
13. Reduction in frequency of fetopathic effects of caffeine in mice by pretreatment with propranolol. Fujii T; Nishimura H Teratology; 1974 Oct; 10(2):149-52. PubMed ID: 4473845 [No Abstract] [Full Text] [Related]
14. [Experimental methods for the detection of teratogens]. Tuchmann-Duplessis H Biol Med (1971); 1974 Nov; 3(2):91-147. PubMed ID: 4620255 [No Abstract] [Full Text] [Related]
15. NTP-CERHR Expert Panel report on the reproductive and developmental toxicity of propylene glycol. Center for the Evaluation of Risks to Human Reproduction Reprod Toxicol; 2004 Jun; 18(4):533-79. PubMed ID: 15135851 [No Abstract] [Full Text] [Related]
16. [Drugs, environment and teratogenesis]. Mariani L Clin Ter; 1976 Apr; 77(1):3-19. PubMed ID: 827412 [No Abstract] [Full Text] [Related]
17. Different embryo-fetal toxicity effects for three VLA-4 antagonists. Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199 [TBL] [Abstract][Full Text] [Related]
18. [A comparison of the sensitive phase for thalidomide in animal experiment and in man]. Lenz W Arch Kinderheilkd; 1968 Sep; 177(3):259-65. PubMed ID: 4975485 [No Abstract] [Full Text] [Related]